U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533955) titled 'A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis' on April 10.
Brief Summary: This is a Phase 1, first in human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE201 compared to placebo in participants with Rheumatoid Arthritis
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Rhematoid Arthritis
Intervention:
DRUG: JADE201
JADE201 is supplied as sterile solution to be administered by SC injection.
DRUG: Placebo
Placebo solution to be administered at a matching volume by SC injection.
Recruitment Status: NOT_YET_RECRUITING...